• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Pediatric Pancreatitis Intensive Care Demand Rose Without Increase in Severity

by
November 17, 2026
in Biology
Reading Time: 6 mins read
0
Pediatric Pancreatitis Intensive Care Demand Rose Without Increase in Severity

Pediatric Pancreatitis Intensive Care Demand Rose Without Increase in Severity

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A 16-year retrospective cohort study conducted at the University Medicine Greifswald has revealed that the rising demand for intensive care in children with pancreatitis is not driven by an increase in disease frequency or severity. The research, which analyzed 184 pediatric inpatients with pancreatitis-related ICD-10 codes admitted between 2010 and 2025, identified 59 patients meeting the standardized INSPPIRE diagnostic criteria. While the institutional data demonstrated a marked concentration of intensive care unit (PICU) admissions in the final two years of the study—specifically between May 2024 and November 2025—the total annual number of patients treated remained stable. The findings indicate that the perceived local escalation in severe pediatric pancreatitis is instead likely a result of shifting clinical practices, including a lower threshold for intensive care admission and the centralization of complex cases following the local introduction of advanced pediatric pancreaticobiliary endoscopy in 2020.

To investigate the clustering of intensive care cases, investigators meticulously reviewed all pediatric pancreatitis admissions to the center over the 16-year study period. The analysis cohort included 44 patients with acute pancreatitis, 7 with acute recurrent pancreatitis, and 8 with chronic pancreatitis. The researchers applied two distinct definitions for intensive care usage: a broad definition counting every patient treated at an intensive care unit at any point during a pancreatitis episode, and a restrictive definition considering only those for whom pancreatitis was the primary reason for intensive care admission. This methodological rigor allowed the team to differentiate between children requiring intensive care for the disease itself and those admitted for other conditions, such as trauma or cancer therapy, where pancreatitis was an accompanying diagnosis.

The study results demonstrated that the annual number of pancreatitis patients did not increase, with 10 patients presenting during the 2024–2025 period compared to 49 patients in the preceding 14 years. Severity grading, performed according to the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) classification, further confirmed that the distribution of mild, moderately severe, and severe disease remained stable across the entire study duration. Specifically, severe disease was recorded in only one of the 10 patients during the 2024–2025 period, while four of the 49 patients seen before this window met the criteria for severe disease. The statistical analysis, which included exploratory Poisson regression, revealed that the observed clustering of nine pancreatitis-driven intensive care admissions—one each in 2011 and 2014, and seven in 2024–2025—was not supported by any corresponding epidemiological change in disease incidence or severity.

The etiology of pediatric pancreatitis in this cohort was consistent with existing literature, with biliary disease and inflammatory bowel disease (IBD) being the most frequent causes, each accounting for 10 patients. Trauma was identified as the leading cause in seven patients, a proportion that the researchers noted is significant for a tertiary center located in a region with high seasonal tourist influx. Only four patients in the cohort remained without a defined etiology after a comprehensive clinical review. Obesity was documented in 13 patients, yet it was primarily associated with biliary disease rather than severity or the requirement for intensive care. These demographic and etiological patterns provide a baseline for understanding the broader clinical spectrum of the condition in a pediatric tertiary referral center setting.

A notable limitation acknowledged by the researchers is the retrospective nature of the study and the potential for systematic under-recording of severity in the earlier years of the 16-year observation period as documentation standards evolved. While this bias could theoretically account for some apparent differences in intensive care usage, it is insufficient to explain the nine-year interval where no pancreatitis-driven intensive care admissions occurred. The study also noted that because case identification relied on ICD-10 discharge coding, the absolute numbers may be limited by coding practices, and future research could benefit from a supplementary laboratory-based search for elevated amylase and lipase levels.

The study underscores the necessity of interdisciplinary cooperation in managing complex pediatric pancreatitis, as seen in the local institutional arrangement established in 2020 between pediatric intensive care, pediatric gastroenterology, and adult interventional gastroenterology. Such collaborations enable in-house therapeutic interventions, such as endoscopic retrograde cholangiopancreatography (ERCP), which was previously unavailable at the center. The research team emphasizes that the concentration of these procedures locally likely facilitated a lower threshold for admitting children to the intensive care unit for closer monitoring and management of complex cases, such as those requiring opioid analgesia or those presenting with necrotizing pancreatitis.

Furthermore, the fatal case described in the study—an adolescent with severe obesity who developed necrotizing pancreatitis—highlights the importance of early detection and rigorous monitoring for sepsis, which remains a primary concern in severe presentations. The research indicates that while genetic variants dominate the landscape for recurrent and chronic pancreatitis, the clinical management of both acute and chronic forms requires careful longitudinal follow-up, given the high prevalence of subsequent complications like exocrine insufficiency and pre-diabetes in survivors. The findings collectively serve as a cautionary example of how institutional changes in capability and referral patterns can create the impression of an epidemiological shift when, in reality, the disease burden remains stable.

In conclusion, the researchers state that pediatric pancreatitis at their institution did not become more frequent or severe over the 16-year observation period, despite the marked recent rise in intensive care use. The study provides a concrete illustration of why a single-center impression of increased severity should be validated against a complete case series before being reported as an epidemiological observation. By distinguishing between genuine changes in disease dynamics and the effects of evolving healthcare delivery models, this cohort study contributes to a more accurate understanding of the clinical surveillance of pediatric pancreatitis in tertiary care settings.

The cohort selection process documented in the study provides detailed accounting for pediatric pancreatitis presentations over the 16-year timeframe. Out of 184 identified inpatient records bearing pancreatitis diagnostic codes, 84 admissions across 19 patients were excluded because their coding represented exocrine pancreatic insufficiency without inflammation, comprising 75 admissions in 11 patients with cystic fibrosis, three admissions in two other children, and six admissions in patients following pancreatic head resection for congenital hyperinsulinism. An additional 25 admissions were excluded as follow-up imaging, elective endoscopic procedures, or recurrences of previously counted patients. After full clinical review of the remaining 75 admissions in 66 patients, six failed to meet standardized diagnostic criteria and one lacked retrievable records, leaving a final cohort of 59 children, including 33 females and 26 males. The median age at index presentation was 12 years, spanning an interquartile range of 8 to 16 years, and overall index hospital stays had a median duration of 7 days. However, patients requiring intensive care experienced substantially prolonged hospitalizations, remaining inpatient for a median of 17 days compared to just 6 days for those managed without intensive care. Additionally, 12 patients resided outside the regional catchment area, representing children of vacationers who fell ill along the Baltic coast.

A detailed examination of intensive care utilization revealed that critical care admissions were not uniformly caused by pancreatitis itself. Among the 15 patients treated in intensive care, six were admitted primarily for other life-threatening conditions with pancreatitis occurring as an accompanying diagnosis, including four admissions following major trauma, one involving chemotherapy toxicity during leukemia treatment, and one for hepatic veno-occlusive disease during stage IV neuroblastoma therapy. For the nine admissions driven strictly by pancreatitis, statistical modeling demonstrated an estimated 30 percent increase per calendar year with a rate ratio of 1.30, an outcome with an expected baseline of only 1.1 admissions across two years under uniform distribution. To confirm these findings against diagnostic variations, the authors evaluated shifting laboratory parameters. Over the 16 years, the hospital laboratory adjusted its upper limit of normal for serum lipase twice, moving from an interval of 1.59 to 6.36 microkatals per liter prior to 2022, to 0.216 to 1.25 in 2024, and 0.2 to 0.88 in 2025. In sensitivity analyses, excluding two adjudicated patients who entered the cohort with enzyme levels below three times normal produced etiology shifts of no more than 2.9 percentage points. Similarly, adding two excluded patients who presented with enzyme elevations between two and three times normal changed proportions by at most 1.5 percentage points, and neither adjustment altered the number of intensive care admissions.

Individual case histories reported in the study illustrate the wide spectrum of pediatric pancreatitis presentations and interventions. In the fatal course, a 13-year-old boy presenting with extreme leukocytosis of 41.6 billion cells per liter, a C-reactive protein of 342 milligrams per liter, and severe hypovolemic shock underwent endoscopic stenting without initial papillotomy because of coagulopathy. Following clinical deterioration from an obstructed stent and secondary bacterial infection, the patient died from multiorgan failure, with Enterobacter cloacae and Enterococcus faecium recovered from blood cultures and pancreatic tissue post-mortem. Conversely, a 16-year-old boy diagnosed with necrotizing pancreatitis and carrying two CTRC genetic variants achieved clinical recovery through delayed, minimally invasive endoscopic drainage. Because his circulatory markers remained stable without requiring catecholamines, clinical teams deferred transgastric drainage with a lumen-apposing metal stent until the necrotic retroperitoneal collection fully encapsulated, after which the stent was safely extracted six weeks later. Earlier records showed that severe phenotypes appeared across the full timeline, including a 17-year-old girl with obesity who required 25 days of hospitalization for necrotizing disease in 2011.

Subject of Research: Clinical epidemiology and intensive care utilization patterns in pediatric pancreatitis patients.

Article Title: Rising demand for intensive care in pediatric pancreatitis without an increase of case numbers or disease severity: a 16-year retrospective single-center cohort study

Article References: Kunkel, F., Wegner, M., Winkler, A., Aghdassi, A., Bahlmann, H., Heckmann, M., & Baier, J. (2026). Rising demand for intensive care in pediatric pancreatitis without an increase of case numbers or disease severity: a 16-year retrospective single-center cohort study. Molecular and Cellular Pediatrics, 13(1), Article 56. https://doi.org/10.1186/s40348-026-00265-w

Image Credits: AI Generated

DOI: 10.1186/s40348-026-00265-w

Keywords: pediatric pancreatitis, intensive care, retrospective cohort study, clinical epidemiology, NASPGHAN, INSPPIRE, pancreaticobiliary endoscopy, tertiary referral center, disease severity, acute pancreatitis, chronic pancreatitis, biliary disease, inflammatory bowel disease, pediatric gastroenterology, healthcare utilization

News Source: Harold Sullivan. (November 17, 2026). Pediatric Pancreatitis Intensive Care Demand Rose Without Increase in Severity. Scienmag.

Tags: acute pancreatitisbiliary diseasechronic pancreatitisclinical epidemiologyDisease severityHealthcare utilizationinflammatory bowel diseaseINSPPIREintensive careNASPGHANpancreaticobiliary endoscopypediatric gastroenterologypediatric pancreatitisretrospective cohort studytertiary referral center
Share12Tweet7Share2ShareShareShare1

Related Posts

Circulating Cell-Free DNA Index Predicts Glioblastoma Progression Risk During Treatment

Circulating Cell-Free DNA Index Predicts Glioblastoma Progression Risk During Treatment

November 18, 2026
Microbes Offer Sustainable Alternative to Petrochemical Diol Manufacturing

Microbes Offer Sustainable Alternative to Petrochemical Diol Manufacturing

November 18, 2026

Optimized CRISPR Protocol Enables Direct Gene Editing in Non-Obese Diabetic Mice

November 18, 2026

Ubiquitin Ligase Receptor DCAF8 Drives Mammary Ductal Elongation and Branching in Mice

November 18, 2026

POPULAR NEWS

  • Early Sensory Differences Prospectively Predict Subsequent Autistic Traits in Longitudinal Cohort

    Early Sensory Differences Prospectively Predict Subsequent Autistic Traits in Longitudinal Cohort

    29 shares
    Share 12 Tweet 7
  • High-Power Spray Coagulation Boosts Efficiency in Colorectal Underwater Endoscopic Dissection

    29 shares
    Share 12 Tweet 7
  • Robotic Latissimus Dorsi Harvest Minimizes Incisions in Complex Breast Reconstruction

    29 shares
    Share 12 Tweet 7
  • Integrated Decision Framework Cuts Costs and Speeds Supply Network Recovery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Circulating Cell-Free DNA Index Predicts Glioblastoma Progression Risk During Treatment

Remote Work Tied to Lower Pandemic Job Concerns in Latin American Survey

Internal Bone Transport Systems Achieved Complete Limb Salvage in Retrospective Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.